TA
CLB icon

Tiedemann Advisors’s Core Laboratories CLB Stock Holding History

Tiedemann Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20,104
Closed -$2.26M – 240
2017
Q3 		$2.26M Buy
20,104
+8,884
+79% +$861K 0.2% 88
2017
Q2 		$1.14M Sell
11,220
-7,124
-39% -$768K 0.08% 195
2017
Q1 		$2.12M Sell
18,344
-968
-5% -$113K 0.18% 113
2016
Q4 		$2.32M Buy
+19,312
New +$2.14M 0.23% 79

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Tiedemann Advisors's CLB Position: Q4 2017 in Review

Tiedemann Advisors sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 20,104 shares — an estimated $2.26M sold.

Tiedemann Advisors first reported a position in CLB in Q4 2016 and held it in 4 quarters. The position peaked at $2.32M in Q4 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Tiedemann Advisors reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Tiedemann Advisors sold 20,104 Core Laboratories shares in Q4 2017, an estimated $2.26M.
  • Tiedemann Advisors first reported a position in Core Laboratories in Q4 2016 and held it in 4 quarters.
  • Tiedemann Advisors's Core Laboratories position peaked at $2.32M in Q4 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Tiedemann Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.